Prospective Analysis of Liver Cancer Treatment and Interventions.

Trial Profile

Prospective Analysis of Liver Cancer Treatment and Interventions.

Completed
Phase of Trial: Phase IV

Latest Information Update: 13 Feb 2015

At a glance

  • Drugs Doxorubicin (Primary) ; Antineoplastics
  • Indications Liver cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 10 Sep 2013 Planned End Date changed from 1 Aug 2016 to 1 Nov 2014 as reported by ClinicalTrials.gov
    • 10 Sep 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov
    • 25 Oct 2012 Planned End Date changed from 1 Aug 2011 to 1 Aug 2016 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top